NasdaqCM - Nasdaq Real Time Price USD

Brainstorm Cell Therapeutics Inc. (BCLI)

Compare
2.0200
-0.0700
(-3.35%)
At close: January 10 at 4:00:01 PM EST
2.0200
0.00
(0.00%)
After hours: January 10 at 5:01:17 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
13,308.0000
--
24,822.0000
24,539.0000
31,684.0000
Operating Income
-13,308.0000
--
-24,822.0000
-24,539.0000
-31,684.0000
Net Non Operating Interest Income Expense
-549.0000
--
545.0000
82.0000
-127.0000
Other Income Expense
-371.0000
--
--
--
--
Pretax Income
-14,228.0000
--
-24,277.0000
-24,457.0000
-31,811.0000
Net Income Common Stockholders
-14,228.0000
--
-24,277.0000
-24,457.0000
-31,811.0000
Diluted NI Available to Com Stockholders
-14,228.0000
--
-24,277.0000
-24,457.0000
-31,811.0000
Basic EPS
-3.45
-6.00
-9.90
-10.20
-16.05
Diluted EPS
-3.45
-6.00
-9.90
-10.20
-16.05
Basic Average Shares
4,453.7240
2,871.7290
2,433.9370
2,412.1160
1,989.8810
Diluted Average Shares
4,453.7240
2,871.7290
2,433.9370
2,412.1160
1,989.8810
Total Operating Income as Reported
-13,308.0000
--
-24,822.0000
-24,539.0000
-31,684.0000
Total Expenses
13,308.0000
--
24,822.0000
24,539.0000
31,684.0000
Net Income from Continuing & Discontinued Operation
-14,228.0000
--
-24,277.0000
-24,457.0000
-31,811.0000
Normalized Income
-13,857.0000
--
-24,277.0000
-24,457.0000
-31,811.0000
Interest Income
--
--
545.0000
82.0000
--
Net Interest Income
-549.0000
--
545.0000
82.0000
-127.0000
EBIT
-13,308.0000
--
-24,822.0000
-24,539.0000
-31,684.0000
EBITDA
-13,055.0000
--
-24,537.0000
-24,279.0000
-31,465.0000
Reconciled Depreciation
253.0000
--
285.0000
260.0000
219.0000
Net Income from Continuing Operation Net Minority Interest
-14,228.0000
--
-24,277.0000
-24,457.0000
-31,811.0000
Total Unusual Items Excluding Goodwill
-371.0000
--
--
--
--
Total Unusual Items
-371.0000
--
--
--
--
Normalized EBITDA
-12,684.0000
--
-24,537.0000
-24,279.0000
-31,465.0000
12/31/2020 - 10/7/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PLUR Pluri Inc.
4.2400
-2.30%
 
BLRX BioLineRx Ltd.
0.1429
+0.21%
 
BONS.TA Bonus BioGroup Ltd.
15.50
+2.65%
 
THTX Theratechnologies Inc.
1.8700
-6.27%
 
MNPR Monopar Therapeutics Inc.
25.35
+3.64%
 
VRCA Verrica Pharmaceuticals Inc.
0.6601
-5.66%
 
CANF Can-Fite BioPharma Ltd.
1.5800
+0.64%
 
AMLX Amylyx Pharmaceuticals, Inc.
3.5000
-7.16%
 
ACET Adicet Bio, Inc.
0.9171
-4.47%
 
CDTX Cidara Therapeutics, Inc.
24.00
-3.54%